UK markets close in 8 minutes

ResMed Inc. (0KW4.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
212.86-2.52 (-1.17%)
As of 03:43PM BST. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.67
52-week change 3-7.87%
S&P500 52-week change 324.19%
52-week high 3240.00
52-week low 3132.67
50-day moving average 3181.11
200-day moving average 3176.89

Share statistics

Avg vol (3-month) 32.99k
Avg vol (10-day) 36.74k
Shares outstanding 5142.5M
Implied shares outstanding 6N/A
Float 8145.47M
% held by insiders 10.82%
% held by institutions 158.77%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 31.88
Trailing annual dividend yield 30.87%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Jun 2021
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 20.91%
Operating margin (ttm)31.29%

Management effectiveness

Return on assets (ttm)11.91%
Return on equity (ttm)22.39%

Income statement

Revenue (ttm)4.58B
Revenue per share (ttm)31.17
Quarterly revenue growth (yoy)7.20%
Gross profit (ttm)N/A
EBITDA 1.44B
Net income avi to common (ttm)958.38M
Diluted EPS (ttm)5.30
Quarterly earnings growth (yoy)29.20%

Balance sheet

Total cash (mrq)259.45M
Total cash per share (mrq)1.77
Total debt (mrq)1.17B
Total debt/equity (mrq)25.21%
Current ratio (mrq)3.04
Book value per share (mrq)31.52

Cash flow statement

Operating cash flow (ttm)1.2B
Levered free cash flow (ttm)955.85M